Health Affairs March 22, 2021
High-quality care depends, in part, on advancing technological solutions. As we look ahead, that progress will increasingly include the ability to perform diagnostic and screening tests at home. COVID-19 has obviously accelerated this trend, and the Food and Drug Administration (FDA) is committed to learning from those experiences, to ensure that, going forward, our nation has the capability to provide remote testing both during the next outbreak and as a part of routine patient care.
Facing any novel outbreak, the first kind of test to be developed is typically a molecular diagnostic test that detects the presence of a virus and its genetic material, such as RNA in the case of SARS-CoV-2. That is because such tests are...